Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse

J Neurosci Res. 2013 Feb;91(2):178-86. doi: 10.1002/jnr.23153. Epub 2012 Nov 22.

Abstract

In chronic demyelinating lesions of the central nervous system, insufficient generation of oligodendrocytes (OLs) is not due to a lack of oligodendrocyte precursor cells (OPCs), because the accumulation of OPCs and premyelinating OLs can be observed within these lesions. Here we sought to identify the basis for the failure of OLs to achieve terminal differentiation in chronic demyelinating lesions through the utilization of plp1-overexpressing (Plp(tg/-)) mice. These mice are characterized by progressive demyelination in young adults and chronic demyelinating lesions at more mature stages. We show that neural stem cells, which are the precursors of OL-lineage cells, are present in the Plp(tg/-) mouse brain and that their multipotentiality and ability to self-renew are comparable to those of wild-type adults in culture. Lineage-tracing experiments using a transgenic mouse line, in which an inducible Cre recombinase is knocked in at the Olig2 locus, revealed that Olig2-lineage cells preferentially differentiated into OPCs and premyelinating OLs, but not into astrocytes, in the Plp(tg/-) mouse brain. These Olig2-lineage cells matured to express myelin basic protein but after that their processes degenerated in the chronic demyelinating lesions of the Plp(tg/-) brain. These results indicate that in chronic demyelinated lesions more OL-lineage cells are produced as part of the repair process, but their processes degenerate after maturation.

MeSH terms

  • Age Factors
  • Animals
  • Antineoplastic Agents, Hormonal / pharmacology
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / metabolism*
  • Brain / pathology
  • Cell Differentiation
  • Cell Lineage / physiology*
  • Demyelinating Diseases / genetics
  • Demyelinating Diseases / metabolism
  • Demyelinating Diseases / pathology
  • Demyelinating Diseases / physiopathology*
  • Disease Models, Animal
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / genetics
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • Mice
  • Mice, Transgenic
  • Myelin Basic Protein / metabolism*
  • Myelin Proteolipid Protein / genetics
  • Myelin Proteolipid Protein / metabolism*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neural Stem Cells / drug effects
  • Neural Stem Cells / physiology
  • Oligodendrocyte Transcription Factor 2
  • Oligodendroglia / physiology*
  • Tamoxifen / pharmacology

Substances

  • Antineoplastic Agents, Hormonal
  • Basic Helix-Loop-Helix Transcription Factors
  • Myelin Basic Protein
  • Myelin Proteolipid Protein
  • Nerve Tissue Proteins
  • Olig2 protein, mouse
  • Oligodendrocyte Transcription Factor 2
  • Plp1 protein, mouse
  • enhanced green fluorescent protein
  • Tamoxifen
  • Green Fluorescent Proteins